Drug: PERINDOPRIL Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125546641 | PERINDOPRIL | Hepatocellular injury | ABBVIE | 61.24 YR | F | 0 | 20160713 | FR |
125581911 | PERINDOPRIL | Hepatocellular injury | GLAXOSMITHKLINE | 58.00 YR | M | 63 KG | 20160714 | FR |
125612861 | PERINDOPRIL | Hepatocellular injury | VIIV | 58.00 YR | M | 63 KG | 20160715 | FR |
125664901 | Perindopril | Hepatocellular injury | UCB | 58.00 YR | M | 63 KG | 20160718 | FR |
125682681 | PERINDOPRIL | Hepatocellular injury | ABBVIE | 58.00 YR | M | 63 KG | 20160718 | FR |
125738821 | PERINDOPRIL | Hepatocellular injury | BRISTOL MYERS SQUIBB | 61.24 YR | F | 0 | 20160720 | FR |
125791211 | PERINDOPRIL | Hepatocellular injury | JANSSEN | 58.00 YR | M | 63 KG | 20160721 | FR |
127886881 | perindopril | Hepatocellular injury | BAXTER | 41.74 YR | M | 0 | 20160928 | FR |
Total Records: 8 Number of Pages: 1